Family offices and advisers
Monitor client portfolios and watchlists for accounting, valuation and disclosure deterioration across US public companies.
Solutions
Built for research teams that need evidence, not unsupported alerts.
KairosIQ Forensic Valuation Console supports portfolio monitoring, downside-risk review, issuer diligence, short-list generation and evidence-backed investment committee workflows.
US public-company focuspublicly available company documents, structured financial records and market evidence
Traceable review indicatorsAnalyst analyst evidence packs and evidence trace records
Institutional workflowPortfolios, reports and watchlists
Controlled usageCredits for high-value outputs
Boutique research teams
Prioritise issuers with unusual revenue quality, inventory, margin, impairment, debt, non-GAAP or narrative-macro signals.
Funds and institutional teams
Use sector heatmaps, portfolio-level monitoring, senior review memos and API access to integrate forensic valuation signals into investment workflows.
KairosIQ Forensic Valuation Console
Designed for evidence-backed public-equity research.
The console helps professional users review forensic valuation risk without exposing underlying proprietary methodology.
Portfolio risk review
Identify holdings with new or persistent forensic valuation signals and view the supporting evidence trail.
Issuer diligence
Open company dashboards with family scores, top drivers, confidence, severity and evidence-pack availability.
Research prioritisation
Rank companies by signal severity, breadth, momentum and cross-family reinforcement.
Committee-ready outputs
Export PDF memos and Excel evidence workbooks for formal review processes.
Review evidence-backed public-company signals with source-linked context.
Request a KairosIQ Forensic Valuation Console demo or log in to the console.